DRDO's 2-DG drug for Covid-19 treatment to be launched next week

The drug has been developed by the DRDO lab Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories.It will be given as an adjunct therapy to Covid patients or an alternative treatment, and its purpose is to assist the primary treatment

from mint - News https://ift.tt/3wdkysx
https://ift.tt/eA8V8J